Straumann stock fell 1.90 percent as Barclays kept Buy rating

Published on 10/04/2026 at 17:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock drew a Buy rating from Barclays at a CHF 120.00 target on October 2, 2026. Q2 revenue reached CHF 1.38 billion and net profit CHF 250.7 million.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen — Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann stock (ISIN CH1175448666) was last at CHF 89.80 on the SIX Swiss Exchange on October 2, 2026, down 1.90 percent from the previous close of CHF 91.54. Markets Insider reported that Barclays maintained a Buy rating and set a CHF 120.00 price target on October 2, 2026.

Barclays keeps its Buy rating

The Barclays target stands CHF 30.20 above the October 2 price, equivalent to 33.63 percent upside. The rating gives Straumann a positive analyst signal even as the stock remains CHF 20.00 below its 52-week high of CHF 109.80.

Markets Insider reported Q2 2026 revenue of CHF 1.38 billion for the quarter ended June 30, 2026, compared with CHF 1.35 billion in Q2 2025. Net profit reached CHF 250.7 million, up from CHF 236.44 million in the year-earlier quarter.

Q2 growth meets valuation debate

The operating picture therefore combines higher reported revenue and profit with a share price that is 18.03 percent below its 52-week high. Straumann sells dental implants, orthodontic products and digital equipment, making China pricing policy and demand for dental procedures important factors for the earnings outlook.

CNBC reported on October 2, 2026 that Goldman Sachs placed Straumann on its October European Conviction List and assigned a CHF 125.00 price target. Goldman analyst Richard Felton cited improving sales growth and business conditions in China, while identifying softer US dental demand and Chinese price reforms as risks.

Consensus target stays higher

Investing.com lists a Buy consensus from 20 analysts, an average 12-month target of CHF 113.05, a high target of CHF 136.00 and a low target of CHF 86.00. The average target is CHF 23.25 above the October 2 price, or 25.89 percent.

Investing.com lists October 28, 2026 as Straumann's next earnings report, giving the market a dated checkpoint for the company's growth and margin trajectory.

Stock remains below its yearly high

Straumann stock was last at CHF 89.80 on October 2, 2026 at 5:30 p.m. CEST, with volume of 678,065 shares. Its 52-week range was CHF 73.02 to CHF 109.80, while market capitalization stood at CHF 14.3 billion.